Overview

Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether an intra-articular injection of DLX105 to the knee joint of patients suffering from severly painful osteoarthritis is safe and reduces pain.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
ESBATech AG
Treatments:
Antibodies
Immunoglobulin Fragments
Immunoglobulins